AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2024
May 15, 2024
31201_dirs_2024-05-14_180f5d00-3a0b-41f6-83c5-c0392fb029ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-05-10
Reporting Person: Weill David (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-10 | Common Stock | S | 2500 | $129.82 | Disposed | 11193 | Direct |
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20
Regulatory Filings
2026
Feb 4